Quinolone Resistance Mechanisms in Salmonella enterica Serovars Hadar, Kentucky, Virchow, Schwarzengrund, and 4,5,12:i:−, Isolated from Humans in Switzerland, and Identification of a Novel qnrD Variant, qnrD2 , in S . Hadar | Zendy

Helga Abgottspon | Zendy; Katrin Zurfluh | Zendy; MagdaleüeschInderbinen | Zendy; Herbert Hächler | Zendy; Roger Stephan | Zendy

Open Access

Quinolone Resistance Mechanisms in Salmonella enterica Serovars Hadar, Kentucky, Virchow, Schwarzengrund, and 4,5,12:i:−, Isolated from Humans in Switzerland, and Identification of a Novel qnrD Variant, qnrD2 , in S . Hadar

Author(s) -

Helga Abgottspon,

Katrin Zurfluh,

MagdaleüeschInderbinen,

Herbert Hächler,

Roger Stephan

Publication year - 2014

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.02404-14

Subject(s) - salmonella enterica , serotype , microbiology and biotechnology , salmonella , biology , quinolone , virology , genetics , bacteria , antibiotics

Human isolates of Salmonella enterica serovars Hadar, Kentucky, Virchow, Schwarzengrund, and the monophasic variant of S. Typhimurium, Salmonella enterica subsp. enterica serovar 4,5,12:i:- were examined for mutations within the quinolone resistance target genes gyrA, gyrB, parC, and parE and for plasmid-mediated resistance genes. Differences were observed among the serovars. A novel variant of qnrD, qnrD2, was detected in an S. Hadar isolate.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research